PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,402,000 | -45.8% | 1,076,000 | -39.9% | 0.09% | -23.5% |
| Q4 2021 | $41,356,000 | -22.5% | 1,790,284 | 0.0% | 0.12% | -18.5% |
| Q3 2021 | $53,350,000 | -12.8% | 1,790,284 | 0.0% | 0.15% | -21.1% |
| Q2 2021 | $61,156,000 | -10.9% | 1,790,284 | -14.2% | 0.18% | -9.3% |
| Q1 2021 | $68,618,000 | -52.8% | 2,086,284 | -11.8% | 0.20% | -49.0% |
| Q4 2020 | $145,413,000 | +55.0% | 2,364,062 | -10.5% | 0.40% | +18.0% |
| Q3 2020 | $93,785,000 | – | 2,641,840 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |